Drawing for BIODGENESIS

USPTO serial 85860091

BIODGENESIS

Reviewed by CopyMark Law Group

Reg. 4410922Status 710
Filing date
Status date
Registration date
Oct 1, 2013
Examiner
FINK, GINA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIODGENESIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eva Tan

Eva Tan Integra LifeSciences Corporation1100 Campus RoadAttn: Law Dept./IP GroupPrinceton, NJ 08540

Goods and services

ClassDescriptionStatusFirst use
005Human allograft tissueSECTION 8 - CANCELLEDMar 7, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2020C8..CANCELLED SEC. 8 (6-YR)—
May 8, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 8, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 8, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 8, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 8, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 5, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 1, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 16, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2013AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Jun 11, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 11, 2013IUAAUSE AMENDMENT ACCEPTED—
Jun 10, 2013DOCKASSIGNED TO EXAMINER—
Mar 15, 2013AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Mar 15, 2013IUAFUSE AMENDMENT FILED—
Mar 14, 2013EAAUTEAS AMENDMENT OF USE RECEIVED—
Mar 4, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance